Matzim La Tablet, Extended Release
NDC Package 52544-693-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Matzim La (diltiazem hydrochloride) tablets is diltiazem is used to treat high blood pressure (hypertension) and prevent chest pain (angina). This formulation utilizes a tablet, extended release delivery system. Marketed by Actavis Pharma, Inc., this product is identified by NDC 52544-693 and is authorized under FDA application ANDA077686.

Identification & Billing

NDC Package Code
52544-693-10
Package Description
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product Code
52544-693
11-Digit Billing Format
52544069310
RxNorm Crosswalk
  • RxCUI: 1091623 - Matzim LA 420 MG 24HR Extended Release Oral Tablet
  • RxCUI: 1091623 - 24 HR diltiazem hydrochloride 420 MG Extended Release Oral Tablet [Matzim]
  • RxCUI: 1091623 - 24 HR Matzim 420 MG Extended Release Oral Tablet
  • RxCUI: 1091623 - Matzim LA 420 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 1091629 - Matzim LA 240 MG 24HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Matzim La
Non-Proprietary Name
Diltiazem Hydrochloride
Substance Name
Diltiazem Hydrochloride
Dosage Form
Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
DILTIAZEM HYDROCHLORIDE 300 mg/1
Pharmacologic Class
Usage Information
Diltiazem is used to treat high blood pressure (hypertension) and prevent chest pain (angina). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. When used regularly, diltiazem can decrease the number and severity of episodes of chest pain from angina. It may help increase your ability to exercise. Diltiazem is called a calcium channel blocker. It works by relaxing blood vessels in the body and heart so blood can flow more easily. Diltiazem also lowers your heart rate. These effects help the heart work less hard and lower blood pressure.

Regulatory & Marketing

Labeler Name
Actavis Pharma, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA077686
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-28-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (52544-693). Click a package code to view its specific billing and regulatory data.

52544-693-19
90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
52544-693-30
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52544-693-10 identifies a specific commercial package of 1000 tablet, extended release in 1 bottle, plastic of Matzim La, a human prescription drug labeled by Actavis Pharma, Inc.. This tablet, extended release is formulated for oral use and contains diltiazem hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Actavis Pharma, Inc. on March 28, 2011. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Diltiazem is used to treat high blood pressure (hypertension) and prevent chest pain (angina). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. When used regularly, diltiazem can decrease the number and severity of episodes of chest pain from angina. It may help increase your ability to exercise. Diltiazem is called a calcium channel blocker. It works by relaxing blood vessels in the body and heart so blood can flow more easily. Diltiazem also lowers your heart rate. These effects help the heart work less hard and lower blood pressure.

How is this Actavis Pharma, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52544069310. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52544-693-10
11-Digit CMS (5-4-2)
52544-0693-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.